Nanoparticle delivery of CRISPR tools
Gold nanoparticles carrying Cas9 ribonucleoprotein and donor DNA, and complexed with endosomal disruptive polymers, correct the DNA mutation that causes Duchenne muscular dystrophy in mice, with minimal off-target effects.
Published in Bioengineering & Biotechnology
Follow the Topic
Biotechnology
Life Sciences > Biological Sciences > Biotechnology
-
Nature Biomedical Engineering
This journal aspires to become the most prominent publishing venue in biomedical engineering by bringing together the most important advances in the discipline, enhancing their visibility, and providing overviews of the state of the art in each field.
Related Collections
With Collections, you can get published faster and increase your visibility.
Biosensing
With this cross-journal Collection, the editors of Communications Biology, Nature Biomedical Engineering, Nature Sensors, Nature Communications, and Scientific Reports welcome the submission of primary research Articles focusing on the development of engineered biosensing devices with the potential to be applied in biomedical research and in the management of disease conditions.
Publishing Model: Hybrid
Deadline: Mar 26, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in
The cover illustrates the delivery of Cas9 ribonucleoprotein and donor DNA by gold nanoparticles, for the correction of a gene mutation.
https://www.nature.com/articles/s41551-017-0137-2
Image design by Karen Moore.